Elite French cyclists participating in the Tour de France over the past 60 years have a significantly lower rate of mortality than French men in the general population, according to the results of a new study.
In evaluating the overall mortality rates of French cyclists who rode in the prestigious event between 1947 and 2012, investigators found the cyclists had a 41% lower mortality rate than men in France and that this lower mortality rate was consistent over time, including periods of reported heavy performance-enhancing-drug use. The lower rate was significant for deaths resulting from cancer and cardiovascular causes, and while it wasn’t statistically significant for other causes of death, the mortality trends all favored the cyclists.
Presenting the results at the European Society of Cardiology (ESC) 2013 Congress, senior investigator Dr Xavier Jouven (Paris Descartes University, France) said that among the cyclists who rode in the Tour…
View original post 137 more words